Daaz Bara Lestari Tbk. vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Daaz Bara Lestari Tbk. trades at Rp1,500 (market cap 3.04T, 171.3K 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp246 (market cap 167.37B, 71K 24h volume). The key difference: Daaz Bara Lestari Tbk. is far larger — about 18.2× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Daaz Bara Lestari Tbk. is more actively traded (171.3K versus 71K). Which is the better fit depends on your goals.
| DAAZ | OBAT | |
|---|---|---|
Market Cap | 3.04T | 167.37B |
Volume | 171.3K | 71K |
Lot | 1.71K | 710 |
Turnover | 258.66M | 17.51M |
Average Price | 1,510 | 246.63 |
Value | 258.66M | 17.51M |
Indicative Equilibrium Price | 1,500 | 246 |
Indicative Equilibrium Volume | 200 | 1 |
Trailing returns across standard periods
Latest headlines on both assets
PT Daaz Bara Lestari Tbk (the Company) was established based on Notarial Deed No. 15, dated November 12, 2009, made before Iswandi, S.H., as the subtitute notary of Yulia S.H., Notary in Jakarta. The ultimate parent of the Company is PT Daaz Nusantara Abadi. The Company started commercial operations in 2019.
Read more on DAAZ →PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →